Shandong Jincheng Pharmaceutical Group Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001500
CNY
14.20
0.35 (2.53%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Net Sales
804.90
571.78
629.60
712.67
858.07
756.74
826.88
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
804.90
571.78
629.60
712.67
858.07
756.74
826.88
Raw Material Cost
549.15
393.96
421.62
503.26
545.05
492.93
556.38
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.29
2.47
2.69
3.36
3.93
4.48
5.22
Selling and Distribution Expenses
122.12
148.67
163.86
140.06
182.37
190.10
179.53
Other Expenses
6.07
2.19
2.82
1.93
3.41
2.68
3.00
Total Expenditure (Excl Depreciation)
734.30
566.95
616.40
665.98
765.48
714.29
771.17
Operating Profit (PBDIT) excl Other Income
70.6
4.8
13.200000000000001
46.7
92.6
42.5
55.7
Other Income
7.24
7.65
5.21
8.82
14.92
7.70
14.78
Operating Profit (PBDIT)
112.68
76.45
92.51
132.23
154.95
118.04
135.04
Interest
2.29
2.47
2.69
3.36
3.93
4.48
5.22
Exceptional Items
0.02
0.04
-0.14
-0.00
0.39
-0.77
0.26
Gross Profit (PBDT)
255.75
177.83
207.97
209.41
313.02
263.81
270.51
Depreciation
82.86
82.86
79.48
79.48
79.92
79.92
81.47
Profit Before Tax
27.55
-8.84
10.20
49.39
71.50
32.87
48.61
Tax
18.77
2.16
1.32
13.50
25.87
9.80
-1.36
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
12.61
-11.81
8.33
35.05
45.73
20.46
47.62
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
12.61
-11.81
8.33
35.05
45.73
20.46
47.62
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.93
0.44
0.34
1.24
-0.09
2.68
2.18
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
8.68
-11.37
8.67
36.30
45.63
23.14
49.80
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
3,663.39
3,650.22
3,697.52
3,747.01
3,766.98
3,699.71
3,716.66
Earnings per share (EPS)
0.03
-0.03
0.02
0.09
0.12
0.05
0.13
Diluted Earnings per share
0.03
-0.03
0.02
0.09
0.12
0.05
0.13
Operating Profit Margin (Excl OI)
2.8%
-2.46%
1.24%
6.16%
7.01%
4.02%
4.69%
Gross Profit Margin
13.72%
12.94%
14.24%
18.08%
17.65%
14.9%
15.73%
PAT Margin
1.57%
-2.06%
1.32%
4.92%
5.33%
2.7%
5.76%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Dec 2025 is 40.77% vs -9.18% in Sep 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Dec 2025 is 176.32% vs -231.03% in Sep 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2025 is 53.20% vs -21.19% in Sep 2025

stock-summary

Interest

QoQ Growth in quarter ended Dec 2025 is -8.00% vs -7.41% in Sep 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

Compare Quarterly Results Of Shandong Jincheng Pharmaceutical Group Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
804.90
0
804.90
Other Operating Income
0.00
0.00
0.00
Total Operating income
804.90
0
804.90
Raw Material Cost
549.15
0
549.15
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.29
0
2.29
Selling and Distribution Expenses
122.12
0
122.12
Other Expenses
6.07
0.00
6.07
Total Expenditure (Excl Depreciation)
734.30
0
734.30
Operating Profit (PBDIT) excl Other Income
70.60
0.00
70.60
Other Income
7.24
0
7.24
Operating Profit (PBDIT)
112.68
0
112.68
Interest
2.29
0
2.29
Exceptional Items
0.02
0
0.02
Gross Profit (PBDT)
255.75
0
255.75
Depreciation
82.86
0
82.86
Profit Before Tax
27.55
0
27.55
Tax
18.77
0
18.77
Provisions and contingencies
0
0
0.00
Profit After Tax
12.61
0
12.61
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
12.61
0
12.61
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.93
0
-3.93
Other related items
0.00
0.00
0.00
Consolidated Net Profit
8.68
0
8.68
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
3,663.39
0
3,663.39
Earnings per share (EPS)
0.03
0
0.03
Diluted Earnings per share
0.03
0
0.03
Operating Profit Margin (Excl OI)
2.80%
0%
0.00
2.80%
Gross Profit Margin
13.72%
0%
0.00
13.72%
PAT Margin
1.57%
0%
0.00
1.57%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 80.49 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 40.77% vs -9.18% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -6.20% vs -11.50% in Dec 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 0.87 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 176.32% vs -231.03% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -80.92% vs -2.36% in Dec 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.54 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is 53.20% vs -21.19% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -24.71% vs 25.34% in Dec 2024

Quarterly - Interest
Interest 0.23 Million
in Dec 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Dec 2025 is -8.00% vs -7.41% in Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 is -41.03% vs -31.58% in Dec 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.80%
in Dec 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025

stock-summary

YoY Growth in quarter ended Dec 2025 has fallen from Dec 2024